Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T MacLaughlin

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Advances in Experimental Medicine and Biology|February 11, 2003
Mullerian inhibiting substance: an updateDavid T MacLaughlin, Patricia K Donahoe
Future Oncology (London, England)|March 13, 2010
Müllerian inhibiting substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancersDavid T MacLaughlin, Patricia K Donahoe
Fertility and Sterility|June 15, 2007
Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significanceDavid B Seifer, David T Maclaughlin
The New England Journal of Medicine|January 23, 2004
Sex determination and differentiationDavid T MacLaughlin, Patricia K Donahoe
Reproductive Sciences (Thousand Oaks, Calif.)|November 25, 2010
The rate of in vitro maturation of primary follicles from adult mice and the quality of oocytes is improved in the absence of anti-mullerian hormoneJoo Hyun Park, David T Maclaughlin, Jose M Teixeira
Human Reproduction (Oxford, England)|January 16, 2007
Serum müllerian-inhibiting substance in Down's syndrome pregnanciesDavid B Seifer, David T MacLaughlin, Howard S Cuckle
Obstetrics & Gynecology Science|September 30, 2014
Müllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumorsJang Heub Kim, David T MacLaughlin, Patricia K Donahoe
The Journal of Clinical Endocrinology and Metabolism|February 8, 2003
The role of Müllerian inhibiting substance in the evaluation of phenotypic female patients with mild degrees of virilizationMadhusmita Misra, David T MacLaughlin, Patricia K Donahoe, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2002
Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidismMadhusmita Misra, David T MacLaughlin, Patricia K Donahoe, et al.
Gynecologic Oncology|April 11, 2009
Serum Müllerian Inhibiting Substance/anti-Müllerian hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiologyHenry L Chang, Nima Pahlavan, Elkan F Halpern, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Advances in Experimental Medicine and Biology|February 11, 2003
Mullerian inhibiting substance: an updateDavid T MacLaughlin, Patricia K Donahoe
Future Oncology (London, England)|March 13, 2010
Müllerian inhibiting substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancersDavid T MacLaughlin, Patricia K Donahoe
Fertility and Sterility|June 15, 2007
Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significanceDavid B Seifer, David T Maclaughlin
The New England Journal of Medicine|January 23, 2004
Sex determination and differentiationDavid T MacLaughlin, Patricia K Donahoe
Reproductive Sciences (Thousand Oaks, Calif.)|November 25, 2010
The rate of in vitro maturation of primary follicles from adult mice and the quality of oocytes is improved in the absence of anti-mullerian hormoneJoo Hyun Park, David T Maclaughlin, Jose M Teixeira
Human Reproduction (Oxford, England)|January 16, 2007
Serum müllerian-inhibiting substance in Down's syndrome pregnanciesDavid B Seifer, David T MacLaughlin, Howard S Cuckle
Obstetrics & Gynecology Science|September 30, 2014
Müllerian inhibiting substance/anti-Müllerian hormone: A novel treatment for gynecologic tumorsJang Heub Kim, David T MacLaughlin, Patricia K Donahoe
The Journal of Clinical Endocrinology and Metabolism|February 8, 2003
The role of Müllerian inhibiting substance in the evaluation of phenotypic female patients with mild degrees of virilizationMadhusmita Misra, David T MacLaughlin, Patricia K Donahoe, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2002
Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidismMadhusmita Misra, David T MacLaughlin, Patricia K Donahoe, et al.
Gynecologic Oncology|April 11, 2009
Serum Müllerian Inhibiting Substance/anti-Müllerian hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiologyHenry L Chang, Nima Pahlavan, Elkan F Halpern, et al.
Pageof 5